Corporate

Mission

We are dedicated to developing, manufacturing, and distributing innovative immunecellular products that address unmet medical needs, particularly within the context of Brazil’s healthcare system.

Through relentless innovation, strategic partnerships, and unwavering commitment to accessibility, we strive to enhance the quality of life for patients while driving sustainable growth and value for our stakeholder.

Overview

BioNK-c is a pioneering biotechnology company dedicated to the development, manufacturing, distribution, and marketing of NK immune cellular advanced therapy products. Based in the USA, but focused on Brazil, we operate within a burgeoning market driven by a robust universal healthcare system, ensuring widespread access to life-saving medicinal products for all citizens.

NK cells therapeutic landscape

Natural Killer (NK) cells are a type of cytotoxic lymphocyte critical to the innate immune system’s defense against viral infections and cancer. Unlike T cells, which require prior sensitization to recognize specific antigens, NK cells can directly recognize and eliminate abnormal cells, such as virus-infected cells or tumor cells, without prior sensitization.

In the immune cellular therapy landscape, NK cells have garnered significant attention due to their potent anti-tumor activity and potential for therapeutic use.